To illustrate, the interaction of programmed cell death ligand 1 (PD-L1) on tumor cells with programmed cell death protein 1 (PD-1) on cytotoxic T lymphocytes has been demonstrated to induce T cell dysfunction, thereby allowing cancer cells to evade immune surveillance (Figure 5a). The gene discussed is PDCD1; the disease is cancer.